THIS PAGE IS NOT MONITORED. PLEASE VISIT US AT https://www.linkedin.com/company/fortrea/
Chiltern has been a valuable part of Fortrea’s legacy since 2017, expanding our clinical trial delivery expertise in oncology, anti-infectives/vaccines and ophthalmology, as well as medical device and diagnostic development. To learn more, follow Fortrea, the Agile CRO. https://www.linkedin.com/company/fortrea/
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network.
Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
1982
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Chiltern founded?
Chiltern was founded in 1982.
What industry is Chiltern in?
Chiltern operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Chiltern based?
Chiltern is headquartered in Durham, United States.
Find investors for your startup like Chiltern
Gritt sends AI-personalised outreach to each investor — from your Gmail
